Innovative Diagnostics FlowMetric Diagnostics develops advanced flow cytometry-based companion diagnostics aimed at the global point-of-care market, presenting a unique opportunity to introduce innovative, high-sensitivity diagnostic solutions to healthcare providers seeking rapid and accurate testing.

Growth in Clinical Market With plans to establish a state-of-the-art FDA-compliant laboratory for CLIA-certified tests, there is a significant opportunity to partner with healthcare institutions, diagnostic labs, and pharmaceutical companies looking to enhance their diagnostic offerings with cutting-edge cytometry solutions.

Expanding Application Scope As flow cytometry moves from research into real-world clinical settings, there is a demand from biotech and pharma firms for reliable, sensitive diagnostics for drug development and personalized medicine that FlowMetric can provide.

Technology Advantage FlowMetric’s proprietary methods combined with modern cytometry technology position it as a potential supplier of advanced diagnostic platforms, appealing to organizations seeking high-precision, scalable diagnostic tools and laboratory automation solutions.

Market Opportunity Targeting global unmet medical needs and emerging health markets, FlowMetric has opportunities to collaborate with international distributors, public health agencies, and global health organizations to expand access to its point-of-care diagnostics.